Description: Dottikon Es Holding AG engages in the manufacture and sale of performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company's chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also provides Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries. In addition, the company is involved in recycling, thermal recovery, and high-temperature incineration of waste streams, as well as wastewater treatment and purification activities; and provision of consulting services for investment companies, and software and engineering services. Dottikon Es Holding AG was founded in 1913 and is headquartered in Dottikon, Switzerland. Dottikon Es Holding AG is a subsidiary of EVOLMA Holding AG.
Home Page: dottikon.com
Hembrunnstrasse 17
Dottikon,
5605
Switzerland
Phone:
41 56 616 81 11
Officers
| Name | Title |
|---|---|
| Dr. Markus Blocher Dipl. Chem., Dr. sc. nat., Ph.D. | Chairman, CEO & MD |
| Ms. Marlene Born Eidg. Dipl. | Chief Financial Officer |
| Dr. Urs Brändli | Head of Processes & Technologies |
| Mr. Kurt Tripolt | Head of Recruiting & Admin. |
| Ms. Karin Krause | Head of HR |
| Dr. Knut Hildebrandt Dipl. Chem., Dr. rer. nat. | Head of Quality Management |
| Dr. Stephan Kirschbaum Dipl. Chem., Dr. rer. nat. | Head of Bus. Devel. |
| Dr. Thomas Rosatzin Ph.D. | Head of Purchasing |
| Dr. Robert Dahinden | Head of Production |
Exchange: SW
Country: CH
Currency: Swiss Franc (CHF)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 48.9964 |
| Price-to-Book MRQ: | 4.8557 |
| Price-to-Sales TTM: | 12.8218 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 670 |